Meeting of the National Vaccine Advisory Committee, 29769-29770 [2014-12014]

Download as PDF Federal Register / Vol. 79, No. 100 / Friday, May 23, 2014 / Notices Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 19, 2014. A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. Progressive National Financial Corporation, Mansfield, Louisiana; to become a bank holding company by acquiring 100 percent of the voting shares of Progressive National Bank of DeSoto Parish, Mansfield, Louisiana. Board of Governors of the Federal Reserve System, May 20, 2014. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2014–11962 Filed 5–22–14; 8:45 am] FEDERAL RESERVE SYSTEM mstockstill on DSK4VPTVN1PROD with NOTICES Notice of Proposals To Engage in or To Acquire Companies Engaged in Permissible Nonbanking Activities The companies listed in this notice have given notice under section 4 of the Bank Holding Company Act (12 U.S.C. 1843) (BHC Act) and Regulation Y, (12 CFR Part 225) to engage de novo, or to acquire or control voting securities or assets of a company, including the companies listed below, that engages either directly or through a subsidiary or other company, in a nonbanking activity that is listed in § 225.28 of Regulation Y (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 19, 2014. A. Federal Reserve Bank of Dallas (E. Ann Worthy, Vice President) 2200 North Pearl Street, Dallas, Texas 75201– 2272: 1. Diamond A Financial, L.P., Maedgen & White, L.P., Hilltop Holdings Inc., and PlainsCapital Corporation, all in Dallas, Texas; to acquire SWS Group, Inc., by merger with an intermediate VerDate Mar<15>2010 18:44 May 22, 2014 Jkt 232001 tier, and indirectly acquire Southwest Securities, Federal Savings Bank, both in Dallas, Texas, and thereby engage in operating a savings association, pursuant to section 225.28(b)(4)(ii). where further information including an agenda will be posted when available. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (301) 458–4EEO (4336) as soon as possible. Board of Governors of the Federal Reserve System, May 20, 2014. Michael J. Lewandowski, Associate Secretary of the Board. [FR Doc. 2014–11963 Filed 5–22–14; 8:45 am] Dated: May 13, 2014. James Scanlon, Deputy Assistant Secretary for Planning and Evaluation, Office of the Assistant Secretary for Planning and Evaluation. BILLING CODE 6210–01–P [FR Doc. 2014–11934 Filed 5–22–14; 8:45 am] BILLING CODE 4151–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Committee on Vital and Health Statistics: Meeting Standards Subcommittee Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. BILLING CODE 6210–01–P 29769 Name: National Committee on Vital and Health Statistics (NCVHS), Subcommittee on Standards. Time and Date: June 10, 2014, 9:00 a.m.– 5:00 p.m. EST. Place: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 705–A, Washington, DC 20024, (202) 690–7100. Status: Open. Purpose: The purpose of this hearing is to review and discuss the current status of selected administrative simplification activities that are a priority for NCVHS in 2014. The objectives of this hearing will be to receive a regulatory update, review and discuss the annual Designated Standards Maintenance Organization (DSMO) Report; discuss the status of development of Operating Rules; review the status of the Coordination of Benefits transaction; discuss new developments in the use of credit cards (including virtual cards) for claim payment; review the status of standards development of Health Care Attachments; discuss the planning and preparation of Health Plan ID; review and discuss the incorporation and use of a Unique Device Identifier (UDI) in administrative transactions; and discuss the status of ICD–10 delay. Contact Person for More Information: Debbie M. Jackson, Acting Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Room 2339, Hyattsville, Maryland 20782, telephone (301) 458–4614 or Terri Deutsch, Centers for Medicare and Medicaid Services, Office of EHealth Standards and Services, 7500 Security Boulevard, Baltimore, Maryland 21244, telephone (410) 786–9462. Program information as well as summaries of meetings and a roster of committee members are available on the NCVHS home page of the HHS Web site: https://www.ncvhs.hhs.gov/, PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting June 10–11, 2014. The meeting is open to the public. However, pre-registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at https:// www.hhs.gov/nvpo/nvac. Participants may also register by emailing nvpo@ hhs.gov or by calling 202–690–5566 to provide your name, organization, and email address. DATES: The meeting will be held on June 10–11, 2014. The meeting times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/ nvac as soon they become available. ADDRESSES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201. The meeting can also be accessed through a live webcast the day of the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/ index.html. SUMMARY: FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. E:\FR\FM\23MYN1.SGM 23MYN1 29770 Federal Register / Vol. 79, No. 100 / Friday, May 23, 2014 / Notices Phone: (202) 690–5566; email: nvpo@ hhs.gov. Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The topics to be discussed at the NVAC meeting will include presentations addressing immunization infrastructure needs at the state and federal levels; an update on successes and remaining challenges for increasing influenza vaccination among healthcare personnel; a discussion of how HHS has supported vaccine innovation and research and development using universal influenza vaccines as an example; updates from the National Vaccine Program Office; and a discussion of on-going community actions to increase human papilloma virus (HPV) vaccination coverage among adolescents. In addition, NVAC working groups on HPV Vaccination and Maternal Immunization will present their recommendations and findings for NVAC consideration and vote. The NVAC Vaccine Confidence Working Group will also provide an update on its progress. The meeting agenda will be posted on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac prior to the meeting. Public attendance at the meeting is limited to the available space. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the Web cast can be found at https://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/ index.html. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Individuals who would like to submit written statements should email mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 18:44 May 22, 2014 Jkt 232001 their comments to the National Vaccine Program Office (nvpo@hhs.gov) at least five business days prior to the meeting. Dated: May 19, 2014. Bruce Gellin, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. 2014–12014 Filed 5–22–14; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Committee on Vital and Health Statistics: Meeting Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. Name: National Committee on Vital and Health Statistics (NCVHS), Full Committee Meeting. Time and Date: June 11, 2014, 9:00 a.m.–5:30 p.m. EDT June 12, 2014, 8:00 a.m.–12:00 p.m. EDT Place: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW., Room 705–A, Washington, DC 20024, (20) 690–7100. Status: Open. Purpose The purpose of this meeting is to review NCVHS Status of Activities, continue to plan for 2014 objectives and deliverables, and review and approve at least one action item: The Eleventh HIPAA Report to Congress. The Committee will also review the deliberative process for the letters submitted for action at the May 15th Conference call—Electronic Standards for Public Health Information Exchange; Findings from the February 2014 hearing; and the ICD 10 delay, and take any follow-up action needed. The Committee will receive a briefing on Data Segmentation initiatives and also an update from the recently conducted June 2014 DataPalooza. Finally, the Working Group on HHS Data Access and Use will continue strategic discussions on usability, use, and usefulness of HHS open data. The times shown above are for the full Committee meeting. Subcommittee issues will be included as part of the Full Committee schedule and identified as ‘‘blocks’’ on the afternoon of the first day and morning the second day. Agendas for these block sessions will be developed later and posted on the NCVHS Web site (URL below) when available. Contact Person for More Information: Substantive program information may be obtained from Debbie M. Jackson, Acting Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Room 2339, Hyattsville, Maryland 20782, telephone (301) 458–4614. Summaries of PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 meetings and a roster of committee members are available on the NCVHS home page of the HHS Web site: https://www.ncvhs.hhs.gov/, where further information including an agenda will be posted when available. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (301) 458–4EEO (4336) as soon as possible. Dated: May 13, 2014. James Scanlon, Deputy Assistant Secretary for Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2014–11935 Filed 5–22–14; 8:45 am] BILLING CODE 4151–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF AGRICULTURE Announcement of the Fourth 2015 Dietary Guidelines Advisory Committee Meeting Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health; and U.S. Department of Agriculture, Food, Nutrition and Consumer Services and Research, Education, and Economics. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act (FACA), the U.S. Department of Health and Human Services (HHS), in collaboration with the U.S. Department of Agriculture (USDA), is hereby giving notice that a meeting of the 2015 Dietary Guidelines Advisory Committee (DGAC) will be held and will be open to the public. DATES: This meeting will be held on July 17, 2014, from 1:15–5:15 p.m. E.D.T. and July 18, 2014 from 8:00 a.m.–3:45 p.m. E.D.T. ADDRESSES: This will not be an inperson meeting. Virtual technology will be utilized to conduct this meeting. The meeting will be accessible by webcast on the Internet. FOR FURTHER INFORMATION CONTACT: Designated Federal Officer (DFO), 2015 DGAC, Richard D. Olson, M.D., M.P.H.; Office of Disease Prevention and Health Promotion, OASH/HHS; 1101 Wootton Parkway, Suite LL100 Tower Building; Rockville, MD 20852: Telephone: (240) 453–8280; Fax: (240) 453–8281; Alternate DFO, 2015 DGAC, Kellie (O’Connell) Casavale, Ph.D., R.D., Nutrition Advisor; Office of Disease Prevention and Health Promotion, OASH/HHS; 1101 Wootton Parkway, Suite LL100 Tower Building; Rockville, MD 20852: Telephone: (240) 453–8280; Fax: (240) 453–8281; Lead USDA CoSUMMARY: E:\FR\FM\23MYN1.SGM 23MYN1

Agencies

[Federal Register Volume 79, Number 100 (Friday, May 23, 2014)]
[Notices]
[Pages 29769-29770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12014]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
June 10-11, 2014. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at https://www.hhs.gov/nvpo/nvac. 
Participants may also register by emailing nvpo@hhs.gov or by calling 
202-690-5566 to provide your name, organization, and email address.

DATES: The meeting will be held on June 10-11, 2014. The meeting times 
and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, 
DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201.

[[Page 29770]]

Phone: (202) 690-5566; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    The topics to be discussed at the NVAC meeting will include 
presentations addressing immunization infrastructure needs at the state 
and federal levels; an update on successes and remaining challenges for 
increasing influenza vaccination among healthcare personnel; a 
discussion of how HHS has supported vaccine innovation and research and 
development using universal influenza vaccines as an example; updates 
from the National Vaccine Program Office; and a discussion of on-going 
community actions to increase human papilloma virus (HPV) vaccination 
coverage among adolescents. In addition, NVAC working groups on HPV 
Vaccination and Maternal Immunization will present their 
recommendations and findings for NVAC consideration and vote. The NVAC 
Vaccine Confidence Working Group will also provide an update on its 
progress. The meeting agenda will be posted on the NVAC Web site: 
https://www.hhs.gov/nvpo/nvac prior to the meeting.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the Web cast can be found at https://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Individuals who would like to submit written statements should 
email their comments to the National Vaccine Program Office 
(nvpo@hhs.gov) at least five business days prior to the meeting.

    Dated: May 19, 2014.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary, 
National Vaccine Advisory Committee.
[FR Doc. 2014-12014 Filed 5-22-14; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.